(Q48244442)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jean-Sébastien Delisle

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

D P Granados

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

A Rodenbrock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

J-P Laverdure

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

C Côté

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

O Caron-Lizotte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

C Carli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

H Pearson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

V Janelle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

C Durette

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

E Bonneil

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

D C Roy

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

S Lemieux

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

P Thibault

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

9 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1344-1354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2016.22

7 March 2020

exact match

0 references

cites work

Neoantigens in cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Adoptive cell transfer as personalized immunotherapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

The future of immune checkpoint therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Adoptive immunotherapy for cancer or viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Antibody-modified T cells: CARs take the front seat for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Next-generation leukemia immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

The immunogenomics of minor histocompatibility antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

The nature of self for T cells-a systems-level perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Advances in graft-versus-host disease biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Targeting cancer-specific mutations by T cell receptor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte-Derived HLA-Ligandome Using a Reverse Immunology Approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

DRiPs solidify: progress in understanding endogenous MHC class I antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Proteogenomics: concepts, applications and computational strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

A map of human genome variation from population-scale sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Minor histocompatibility antigens: past, present, and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Distribution and characterization of regulatory elements in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

The MHC class I peptide repertoire is molded by the transcriptome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Proteome sampling by the HLA class I antigen processing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

An open-source computational and data resource to analyze digital maps of immunopeptidomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Cytotoxic T lymphocytes for leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

The use of endogenous T cells for adoptive transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Development of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Adoptive cellular therapy: a race to the finish line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.22

Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients

21 January 2018

1 reference

12 December 2020

Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

1 reference

12 December 2020

Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease

1 reference

12 December 2020

Immunodominant minor histocompatibility antigens: the major ones

1 reference

12 December 2020

T cells targeted against a single minor histocompatibility antigen can cure solid tumors

1 reference

12 December 2020

A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2016.22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857467%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference